Life Settlements industry publication The Life Settlements Report, part of The Deal, publishes data each year on the size of the secondary market in life settlements, where individual policies are purchased by investors from the original owner through intermediaries. Much of the data comes from freedom of information requests to state insurers, and only a small percentage is contributed directly by providers.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains
One of the findings from the 2025 ELSA–Conning Life Settlement Investor Sentiment Study was that…
2025 Provides Activity, Change and Evolution for UK Pension Risk Transfer Market
The past 12 months have seen significant developments that are likely to shape mortality models…
US Plan Sponsors Are Turning to OCIOs for Buy-Out Readiness
There is plenty of investment work still to do even for those US plan sponsors…
Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI
The latest data on excess mortality in England, published by the Office for Health Improvement…
